PCSK9 inhibitor antibodies for the treatment of hyperlipidemic patients undergoing lipoprotein apheresis

MA42657AUndetermined Publication Date: 2018-06-27REGENERON PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MA42657
Authority / Receiving Office
MA · MA
Patent Type
Applications
Current Assignee / Owner
Priority Date
2016-07-27
Filing Date
2016-08-17
Publication Date
2018-06-27
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.